# CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)

> **NCT02230241** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 2700 (actual)

## Conditions studied

- Dyslipidaemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02230241
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 2700 (ACTUAL)
- **Last updated:** 2016-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02230241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02230241, "CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02230241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*